FRANK E. THOMAS - 01 Apr 2022 Form 4 Insider Report for Orchard Therapeutics plc

Role
Title: President & Chief Operating Officer
Signature
/s/ Frank Thomas
Issuer symbol
N/A
Transactions as of
01 Apr 2022
Net transactions value
+$7,474
Form type
4
Filing time
04 Apr 2022, 16:15:43 UTC
Previous filing
07 Jan 2022
Next filing
12 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORTX Ordinary Shares Purchase $7,474 +10,000 +24% $0.7474 52,081 01 Apr 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.722 to $0.758. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Remarks:

Title: President & Chief Operating Officer